Skip to content
Colorectal Cancer Clinical Trials

Orange, California

Colorectal cancer clinical trials in Orange, CA

23 colorectal cancer studies are recruiting participants at sites in Orange as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Orange at a glance

  • 23 studies are recruiting at a site in Orange.
  • By phase: Phase 1 (6), Phase 1/2 (7), Phase 2 (5), Phase 2/3 (2), Phase 3 (2), Observational (1).
  • By sponsor: industry (11), university, hospital or other (8), government (4).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Orange

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    University of California Irvine
    Registry record
    NCT06324357 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    UC Irvine Health-Chao Family Comprehensive Cancer Center
    Registry record
    NCT07488676 · updated
  3. Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT06102902 · updated
  4. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  5. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Saint Joseph Hospital - Orange
    Registry record
    NCT05174169 · updated
  6. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT05673148 · updated
  7. Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT05803382 · updated
  8. A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    University of California, Irvine (UCI) Health - UC Irvine Medical Center
    Registry record
    NCT07221357 · updated
  9. Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT06654037 · updated
  10. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    UC IRVINE Health
    Registry record
    NCT06128551 · updated
  11. Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    • Phase 1
    • Ages 12 to 85
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Study site
    Children's Hospital of Orange County-Rady Children's Health
    Registry record
    NCT03715933 · updated
  12. Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center, University of California, Irvine
    Registry record
    NCT07795749 · updated
  13. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    Children's Hospital of Orange County
    Registry record
    NCT04851119 · updated
  14. Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT05691491 · updated
  15. Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Canadian Cancer Trials Group
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT06205485 · updated
  16. Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center, University of California Irvine
    Registry record
    NCT06580002 · updated
  17. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    UC Irvine/Chao Family Comprehensive Cancer Center
    Registry record
    NCT05379985 · updated
  18. Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center, University of California, Irvine
    Registry record
    NCT04920032 · updated
  19. TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Teclison Ltd.
    Study site
    University of California, Irvine Medical Center
    Registry record
    NCT04701476 · updated
  20. A Study of VET3-TGI in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    KaliVir Immunotherapeutics
    Study site
    UC Irvine Health
    Registry record
    NCT06444815 · updated
  21. Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center, University of California Irvine
    Registry record
    NCT07447050 · updated
  22. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    • Observational
    • All ages
    • All sexes
    Sponsor
    Massive Bio, Inc.
    Study site
    Massive Bio SYNERGY-AI site
    Registry record
    NCT03452774 · updated
  23. 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

    • Phase 1/2
    • Ages 15 and older
    • All sexes
    Sponsor
    Lantheus Medical Imaging
    Study site
    UC Irvine Health - Chao Family Comprehensive Cancer Center
    Registry record
    NCT06298916 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Orange, CA on ClinicalTrials.gov.

Ask about studies near Orange

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call